Activity of the potent dual Abl/Src tyrosine kinase inhibitor FB2 against Bcr–Abl positive cell lines in vitro and in vivo

Authors

Keywords

Journal

Volume 35, Issue 2, Pages 237-242

Publisher

Elsevier BV

Online

2010-08-24

DOI

10.1016/j.leukres.2010.07.041

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now